phone icon303-444-6950 | 301-913-0213
divider

News

separator

Stardog Adds Dan Yates to its Board of Directors

You will be redirected to: https://www.prweb.com/releases/stardog_adds_dan_yates_to_its_board_of_directors/prweb15972195.htm
Read More
separator

miRagen Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

You will be redirected to: http://investors.miragen.com/Cache/1500114890.PDF?O=PDF&T=&Y=&D=&FID=1500114890&iid=4890649
Read More
separator


Science Meets Gratitude – Array BioPharma

Sorry, but you do not have permission to view this content.

Read More
separator

SyncHR and Hitachi Consulting Join Forces to Expand Reach of Cloud Human Capital Management Technology

You will be redirected to: https://globenewswire.com/news-release/2018/09/05/1565735/0/en/SyncHR-and-Hitachi-Consulting-Join-Forces-to-Expand-Reach-of-Cloud-Human-Capital-Management-Technology.html
Read More
separator

Array BioPharma Names Carrie S. Cox Chairman of its Board of Directors

You will be redirected to: http://investor.arraybiopharma.com/news-releases/news-release-details/array-biopharma-names-carrie-s-cox-chairman-its-board-directors
Read More
separator

miRagen Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update

You will be redirected to: http://investors.miragen.com/file/Index?KeyFile=394547646
Read More
separator

Array BioPharma Announces FDA Approval OF Braftovi™ (Encorafenib) in Combination with Mektovi® (Binimetinib)

You will be redirected to: http://investor.arraybiopharma.com/news-releases/news-release-details/array-biopharma-announces-fda-approval-braftovitm-encorafenib
Read More
separator

Michael Sachse Named CEO of Stardog

You will be redirected to: https://www.prweb.com/releases/2018/06/prweb15573382.htm
Read More
separator

Miragen Therapeutics to Present First Cobomarsen Phase 1 Clinical Trial Data From Patients With Adult T-Cell Leukemia/lymphoma and New Interim Data From Patients With Mycosis Fungoides at the 2018 American Society of Clinical Oncology Annual Meeting

You will be redirected to: http://investors.miragen.com/file/Index?KeyFile=393751965
Read More
separator

Array BioPharma Announces Additional Median Overall Survival Results of Encorafenib and Binimetinib in Patients with BRAF-mutant Advanced Melanoma

You will be redirected to: http://investor.arraybiopharma.com/news-releases/news-release-details/array-biopharma-announces-additional-median-overall-survival
Read More
separator